» Articles » PMID: 33794296

HIV-1 and Drug Abuse Comorbidity: Lessons Learned from the Animal Models of NeuroHIV

Overview
Journal Neurosci Lett
Specialty Neurology
Date 2021 Apr 1
PMID 33794296
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Various research studies that have investigated the association between HIV infection and addiction underpin the role of various drugs of abuse in impairing immunological and non-immunological pathways of the host system, ultimately leading to augmentation of HIV infection and disease progression. These studies have included both in vitro and in vivo animal models wherein investigators have assessed the effects of various drugs on several disease parameters to decipher the impact of drugs on both HIV infection and progression of HIV-associated neurocognitive disorders (HAND). However, given the inherent limitations in the existing animal models of HAND, these investigations only recapitulated specific aspects of the disease but not the complex human syndrome. Despite the inability of HIV to infect rodents over the last 30 years, multiple strategies have been employed to develop several rodent models of HAND. While none of these models can accurately mimic the overall pathophysiology of HAND, they serve the purpose of modeling some unique aspects of HAND. This review provides an overview of various animal models used in the field and a careful evaluation of methodological strengths and limitations inherent in both the model systems and study designs to understand better how the various animal models complement one another.

Citing Articles

Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions.

Namba M, Xie Q, Barker J Brain Behav Immun. 2023; 113:453-475.

PMID: 37567486 PMC: 10528352. DOI: 10.1016/j.bbi.2023.07.021.


Opioid abuse and SIV infection in non-human primates.

Deshetty U, Ray S, Singh S, Buch S, Periyasamy P J Neurovirol. 2023; 29(4):377-388.

PMID: 37418108 PMC: 10729652. DOI: 10.1007/s13365-023-01153-z.


Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats.

Ezeomah C, Fongsaran C, Persons A, Napier T, Cisneros I Cells. 2022; 11(15).

PMID: 35954251 PMC: 9368446. DOI: 10.3390/cells11152405.


Inflammasomes as mediators of inflammation in HIV-1 infection.

Min A, Fortune T, Rodriguez N, Hedge E, Swartz T Transl Res. 2022; 252():1-8.

PMID: 35917903 PMC: 10160852. DOI: 10.1016/j.trsl.2022.07.008.


Covid-19 interface with drug misuse and substance use disorders.

Cisneros I, Cunningham K Neuropharmacology. 2021; 198:108766.

PMID: 34454912 PMC: 8388132. DOI: 10.1016/j.neuropharm.2021.108766.

References
1.
Jantzie L, Rauw G, Todd K . The effects of doxycycline administration on amino acid neurotransmitters in an animal model of neonatal hypoxia-ischemia. Neurochem Int. 2006; 49(8):717-28. DOI: 10.1016/j.neuint.2006.06.010. View

2.
Griffin 3rd W, Middaugh L, Cook J, Tyor W . The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: deficits in cognitive function. J Neurovirol. 2004; 10(2):109-15. DOI: 10.1080/13550280490428333. View

3.
Marcondes M, Burudi E, Huitron-Resendiz S, Sanchez-Alavez M, Watry D, Zandonatti M . Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J Immunol. 2001; 167(9):5429-38. DOI: 10.4049/jimmunol.167.9.5429. View

4.
Paris J, Carey A, Shay C, Gomes S, He J, McLaughlin J . Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice. Neuropsychopharmacology. 2013; 39(2):380-8. PMC: 3870789. DOI: 10.1038/npp.2013.201. View

5.
Burdo T, Lackner A, Williams K . Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev. 2013; 254(1):102-13. PMC: 3704190. DOI: 10.1111/imr.12068. View